A multidimensional approach to male urinary incontinence: treatment efficacy and mental health perspectives

Male urinary incontinence (UI) is a prevalent yet under-discussed condition that has a significant impact on patient quality of life and social, emotional and physical well-being. UI in men can arise as stress incontinence, urge incontinence, or mixed incontinence depending on the timing and manifestation of urinary leakage. The economic implications of UI are substantial, with UI in men leading to billions in healthcare costs annually in the United States alone. UI is associated with decreased quality of life and depression, particularly among socioeconomically vulnerable populations. For men, this condition can cause emotional and financial distress, affecting quality of life, social reintegration, and professional activities. Addressing the mental health aspects of UI through screening, open communication, and tailored interventions is crucial for improving patient outcomes and quality of life. The diagnostic process for UI begins with a thorough history and physical examination to classify the type and severity, which dictates the treatment approach. Other office-based diagnostic tools can help to accurately characterize symptoms and assess impact on quality of life. For complex cases or when standard diagnostics fail to clarify the condition, referrals to urologic specialists for advanced testing are recommended. Conservative management is always preferred as the first-line therapy for UI, including for stress, urge and mixed incontinence. Medications tend to be more effective and prevalent in the management and treatment for urge incontinence while surgical interventions are likely to give the best outcomes for stress incontinence. Referral to a urologic specialist is often necessitated in complex cases or for surgical treatment of UI. In this study, we provide a comprehensive analysis of male UI, enhance understanding and awareness of the condition, guide management practices to improve patient outcomes, and explore the economic burden and mental health implications of UI in men.

Urinary incontinence; Male urinary incontinence; Urinary incontinence management; Urinary incontinence treatment; Urinary incontinence diagnosis; Stress urinary incontinence; Urge urinary incontinence; Mixed urinary incontinence

[1] Buckley BS, Lapitan MCM. Prevalence of urinary incontinence in men, women, and children—current evidence: findings of the fourth international consultation on incontinence. Urology. 2010; 76: 265–270.

[2] Markland AD, Goode PS, Redden DT, Borrud LG, Burgio KL. Prevalence of urinary incontinence in men: results from the national health and nutrition examination survey. Journal of Urology. 2010; 184: 1022–1027.

[3] Nandy S, Ranganathan S. Urge incontinence. StatPearls Publishing: Treasure Island (FL). 2022.

[4] Kobashi KC, Vasavada S, Bloschichak A, Hermanson L, Kaczmarek J, Kim SK, et al. Updates to surgical treatment of female stress urinary incontinence (SUI): AUA/SUFU guideline (2023). Journal of Urology. 2023; 209: 1091–1098.

[5] Sandhu JS, Breyer B, Comiter C, Eastham JA, Gomez C, Kirages DJ, et al. Incontinence after prostate treatment: AUA/SUFU guideline. Journal of Urology. 2019; 202: 369–378.

[6] Inouye BM, Premo HA, Weil D, Peterson AC. The male sling for stress urinary incontinence: tips and tricks for success. International Brazilian Journal of Urology. 2021; 47: 1131–1135.

[7] Lantz A, Bock D, Akre O, Angenete E, Bjartell A, Carlsson S, et al. Functional and oncological outcomes after open versus robot-assisted laparoscopic radical prostatectomy for localised prostate cancer: 8-year follow-up. European Urology. 2021; 80: 650–660.

[8] Gupta S, Ding L, Granieri M, Le N, Peterson AC. Utilization of surgical procedures and racial disparity in the treatment of urinary incontinence after prostatectomy. Neurourology and Urodynamics. 2016; 35: 733–737.

[9] Radadia KD, Farber NJ, Shinder B, Polotti CF, Milas LJ, Tunuguntla HSGR. Management of postradical prostatectomy urinary incontinence: a review. Urology. 2018; 113: 13–19.

[10] Gupta S, Peterson AC. Stress urinary incontinence in the prostate cancer survivor. Current Opinion in Urology. 2014; 24: 395–400.

[11] Bauer RM, Gozzi C, Hübner W, Nitti VW, Novara G, Peterson A, et al. Contemporary management of postprostatectomy incontinence. European Urology. 2011; 59: 985–996.

[12] Shamliyan TA, Wyman JF, Ping R, Wilt TJ, Kane RL. Male urinary incontinence: prevalence, risk factors, and preventive interventions. Reviews in Urology. 2009; 11: 145–165.

[13] Rahnama’i MS, Marcelissen T, Geavlete B, Tutolo M, Hüsch T. Current management of post-radical prostatectomy urinary incontinence. Frontiers in Surgery. 2021; 8: 647656.

[14] Yafi FA, Powers MK, Zurawin J, Hellstrom WJG. Contemporary review of artificial urinary sphincters for male stress urinary incontinence. Sexual Medicine Reviews. 2016; 4: 157–166.

[15] Bernal RM, Peterson AC. Evaluation of postprostatectomy incontinence: determining candidacy for the transobturator sling. Current Bladder Dysfunction Reports. 2012; 7: 215–221.

[16] Chen Y, Hao H, Chen S, Chen X, Liu Y, Zhang M, et al. Insights into urinary incontinence after robot-assisted radical prostatectomy: urgent urinary incontinence or stress urinary incontinence. World Journal of Urology. 2023; 41: 3635–4362.

[17] Kim MM, Harvey J, Gusev A, Norton JM, Miran S, Bavendam T. A scoping review of the economic burden of non-cancerous genitourinary conditions. Urology. 2022; 166: 29–38.

[18] Stothers L, Thom D, Calhoun E. Urologic diseases in America project: urinary incontinence in males—demographics and economic burden. Journal of Urology. 2005; 173: 1302–1308.

[19] Powell LC, Szabo SM, Walker D, Gooch K. The economic burden of overactive bladder in the United States: a systematic literature review. Neurourology and Urodynamics. 2018; 37: 1241–1249.

[20] Kleinman NL, Chen C-I, Atkinson A, Odell K, Zou KH. Economic burden of urge urinary incontinence in the workplace. Journal of Occupational and Environmental Medicine. 2014; 56: 266–269.

[21] Della Volpe K. Effects of urinary incontinence on long-term care facilities. 2021. Accessible at: https://www.clinicaladvisor.com/home/meeting-coverage/gapna-2021/effects-urinary-incontinence-long-term-care-settings/ (Accessed: April 3, 2024).

[22] Filipas DK, Labban M, Beatrici E, Stone BV, Qian ZJ, Zaplatnikova A, et al. Association of urinary incontinence and depression: findings from the national health and nutrition examination survey. Urology. 2023; 181: 11–17.

[23] Pizzol D, Demurtas J, Celotto S, Maggi S, Smith L, Angiolelli G, et al. Urinary incontinence and quality of life: a systematic review and meta-analysis. Aging Clinical and Experimental Research. 2021; 33: 25–35.

[24] Wu S, Wu F. Association of urinary incontinence with depression among men: a cross-sectional study. BMC Public Health. 2023; 23: 944.

[25] Abrams P, Andersson K, Apostolidis A, Birder L, Bliss D, Brubaker L, et al. 6th international consultation on incontinence. recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Neurourology and Urodynamics. 2018; 37: 2271–2272.

[26] Tran LN, Puckett Y. Urinary incontinence. StatPearls Publishing: Treasure Island (FL). 2023.

[27] Lugo T, Riggs J. Stress incontinence. StatPearls Publishing: Treasure Island (FL). 2023.

[28] Gacci M, Sakalis VI, Karavitakis M, Cornu J-N, Gratzke C, Herrmann TRW, et al. European association of urology guidelines on male urinary incontinence. European Urology. 2022; 82: 387–398.

[29] Cameron AP, Chung DE, Dielubanza EJ, Enemchukwu E, Ginsberg DA, Helfand BT, et al. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. The Journal of Urology. 2024; 212: 11–20.

[30] ProACTTM. Adjustable continence therapy for men. Accessible at: https://www.uromedica-inc.com/proact (Accessed: April 2, 2024).

[31] Finazzi Agrò E, Gregori A, Bianchi D, Carone R, Giammò A, Ammirati E, et al. Efficacy and safety of adjustable balloons (ProactTM) to treat male stress urinary incontinence after prostate surgery: medium and long-term follow-up data of a national multicentric retrospective study. Neurourology and Urodynamics. 2019; 38: 1979–1984.

[32] Riemsma R, Hagen S, Kirschner-Hermanns R, Norton C, Wijk H, Andersson K-E, et al. Can incontinence be cured? A systematic review of cure rates. BMC Medicine. 2017; 15: 63.

[33] Kelleher C, Hakimi Z, Zur R, Siddiqui E, Maman K, Aballéa S, et al. Efficacy and tolerability of mirabegron compared with antimuscarinic monotherapy or combination therapies for overactive bladder: a systematic review and network meta-analysis. European Urology. 2018; 74: 324–333.

[34] Kotecha P, Sahai A, Malde S. Use of duloxetine for postprostatectomy stress urinary incontinence: a systematic review. European Urology Focus. 2021; 7: 618–628.

[35] Tricard T, Song QX, Munier P, Li JY, Leng J, Saussine C, et al. Adjustable continence therapy (proACT) for the treatment of male stress urinary incontinence post-prostatectomy: a systematic review and meta-analysis (2023 update). World Journal of Urology. 2023; 41: 1793–1802.